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Abstract
RelBE represents a typical bacterial toxin-antitoxin (TA) system. Mycobacterium tuberculosis H37Rv, the pathogen responsible
for human tuberculosis, contains three RelBE-like modules, RelBE, RelFG, and RelJK, which are at least partly expressed in
human macrophages during infection. RelBE modules appear to be autoregulated in an atypical manner compared to other
TA systems; however, the molecular mechanisms and potential interactions between different RelBE modules remain to be
elucidated. In the present study, we characterized the interaction and cross-regulation of these Rel toxin-antitoxin modules
from this unique pathogen. The physical interactions between the three pairs of RelBE proteins were confirmed and the
DNA-binding domain recognized by three RelBE-like pairs and domain structure characteristics were described. The three
RelE-like proteins physically interacted with the same RelB-like protein, and could conditionally regulate its binding with
promoter DNA. The RelBE-like modules exerted complex cross-regulation effects on mycobacterial growth. The relB
antitoxin gene could replace relF in cross-neutralizing the relG toxin gene. Conversely, relF enhanced the toxicity of the relE
toxin gene, while relB increased the toxicity of relK. This is the first report of interactions between different pairs of RelBE
modules of M. tuberculosis.
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Introduction
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB),
continues to pose a serious threat to human health [1]. The
persistence, dormancy, and multidrug resistance of this organism
and its current co-infection with human immunodeficiency virus
(HIV) now make global tuberculosis control particularly challeng-
ing [2]. Eradication of tuberculosis is also hampered by our poor
understanding of the strategies used by this pathogen for surviving
in a dormant state within the phagosome following infection of
macrophages [3].
As in a number of other pathogens, dormant infection of M.
tuberculosis is likely to involve bacterial toxin-antitoxin (TA) systems,
which are ubiquitous in free-living bacteria and archaea [4-6]. TA
modules are defined as protein pairs consisting of a toxin and its
antitoxin; the antitoxin can bind to the toxin and neutralize its
toxic effects [3]. In typical growth conditions, a pair of toxin-
antitoxin proteins will exist as a stable complex [7,8]. However, in
response to stressful or unfavorable growth conditions, the
antitoxin is often triggered to degrade, which results in liberation
of the toxin. The toxin then exerts its deleterious effects on the host
cell [7,8]. M. tuberculosis contains more than 38 toxin-antitoxin loci
[8,9].
Of the bacterial TA systems, the RelBE module is one of the
best studied [4,10,11]. The toxin induces a global inhibition of
translation and arrest of cell growth by cleaving mRNA and
tmRNA [4,8,11–14]. In E. coli, RelB has been shown to auto-
regulate relBE transcription by binding to the relBE promoter
region, whereas the combined toxin-antitoxin complex strongly
inhibits relBE transcription [15–20]. The M. tuberculosis genome
harbors three pairs of relBE loci, Rv1247c-Rv1246c, Rv2865-
Rv2866 and Rv3357-Rv3358, designated as RelBE, RelFG, and
RelJK, respectively [8,9,21].
Although each pair of M. tuberculosis relBE-like genes can form an
autoregulatory operon, the regulation patterns appear to be
different from those described for a typical TA module [21]. Of
the three RelBE pairs, only one toxin (RelJ) has been shown to act
as a corepressor of expression. The other two (RelB and RelF) act
as transcriptional activators [21]. This indicates that unique
intracellular pathogens such as M. tuberculosis might show more
complex regulation of the expression of their rel operons. The
actual molecular mechanisms remain to be elucidated in this
human pathogen. However, over-expression of individual toxin
genes induces growth arrest in a related species, M. smegmatis. This
phenotype is completely reversible by expression of the cognate
antitoxin genes, providing an excellent vehicle for studying the
regulation of these genes [21].
In the current study, we have characterized the physical
interactions between all three RelB/RelE protein pairs, as well as
their interactions with each cognate promoter. The binding
regions and sequence characteristics for three RelBE proteins were
identified. The RelJ-RelK pair was found to have different
regulatory characteristics compared to the other two. In addition,
cross regulation between different RelBE modules was examined
PLoS ONE | www.plosone.org 1 May 2010 | Volume 5 | Issue 5 | e10672in vitro and in vivo in M. smegmatis. In particular, two RelB-like
proteins were observed to interact with all three RelE-like proteins,
RelE, RelG, and RelK.
Results
Three M. tuberculosis RelB-like proteins physically interact
with their cognate RelE-like proteins
The interaction between RelB antitoxin and RelE toxin proteins
has been previously characterized [21]. In the present study, we
first used a bacterial two-hybrid technique to detect the
interactions between the three pairs of M. tuberculosis RelBE-like
proteins. As shown in Fig. 1A and B, a positive co-transformant
(CK
+) grew on a Screening Medium, but the negative co-
transformant (CK
2) did not grow at all. The co-transformant of
RelB/RelE grew well on the screening medium, indicating that
the RelB interacted with RelE. Similarly, both RelF/RelG and
RelJ/RelK co-transformants grew on the screening medium
(Fig. 1A, B), while no growth was observed for their self-activated
controls, or for their co-transformants expressing a non-specific
Figure 1. Physical interactions between three pairs of M. tuberculosis RelBE-like proteins. (A) The BacterioMatch II two-hybrid system
(Stratagene) was used to detect protein-protein interactions of RelBE protein pairs, as described in the ‘‘Materials and Methods’’. Left panel: plate
minus streptomycin (str) and 8 mM 3-amino-1, 2, 4-triazole (3-AT). Right panel: plate plus 12 mg/mL str and 8 mM 3AT. (B) An outline of the plates in
A, CK+: co-transformant containing pBT-LGF2 and pTRG-Gal11P as a positive control. CK-: co-transformant containing pBT and pTRG as a negative
control. Each unit represents the corresponding co-transformant in the plates. A non-specific protein, Rv2034, was used as an additional control. (C)
Pull-down assays for examining the specific interaction between three RelBE protein pairs. The proteins were purified for this assay. Equimolar
amounts of 66His-RelB combined with GST-RelE were used for pull-down assays as described in the ‘‘Materials and Methods’’. GST was used as the
negative control. One predicted size of his-tagged RelB protein, pulled down by their respective cognate GST-tagged RelE protein, was further
examined by a Western blotting assay (Fig. 1C, lane 2). ‘‘Input’’ represents a sample removed after the GST-tagged and His-tagged proteins had been
combined in the mixture.
doi:10.1371/journal.pone.0010672.g001
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interactions between all three pairs of RelBE homologs of M.
tuberculosis.
To confirm these observations, GST pull-down assays were
used to characterize the direct physical interactions of the RelBE-
like pairs. As shown in Fig. 1C, each pair of RelBE-like proteins
was co-purified. One predicted size of his-tagged Rel protein could
be readily pulled down by its respective cognate GST-tagged Rel
protein, which was clearly demonstrated by a further Western
blotting assay (Fig. 1C, lane 2). GST co-incubated with his-tagged
Rel proteins did not produce any specific bands (Fig. 1C, lane 3).
Auto-interaction and conditional cooperativity of three
M. tuberculosis RelBE-like modules
Promoter DNA (described as 1247p, 2865p, and 3357p below)
was used as substrate to further investigate the in vitro association of
RelBE with promoters. As shown in Fig. 2A, of the three RelB-like
proteins (from 3.75 to 15 mM), only RelJ associated strongly with
its promoter as a singular protein and produced a substantial
shifted protein/DNA complex band (Fig. 2A). In contrast, no
complex was observed for either the single RelB or RelF antitoxin
proteins under similar experimental conditions.
Electrophoretic mobility shift assays (EMSA) were conducted to
investigate the effect of the physical interaction between a RelB-
like and a RelE-like protein on their promoter-binding abilities. As
shown in Fig.2B, neither RelB (7.5 mM) nor RelE (7.5 mM) alone
could bind with the promoter. However, as the ratio of RelB/RelE
was increased in the reaction mixture (from 8:1 to 2:1)(Fig. 2B,
lane 4-6), a shifted protein/DNA complex band appeared. The
best binding activity was observed when the ratio of RelB/RelE
reached 2:1 (Fig. 2B, lane 6). However, significant inhibition
appeared if the ratio was further increased (from 1:1 to 1:4) and
the protein/DNA complex band disappeared (Fig. 2B, lane 7–9).
A similar result was also observed for the interaction between RelF
and RelG (Fig. 2C).
As seen in Fig. 2D, neither RelJ alone nor RelK alone formed
shifted complexes at a concentration of 3.75 mM (Lane 2 and 3).
Four obvious protein/DNA complex bands were observed for the
combined RelJ/RelK complex (indicated as band1, 2, 3 and 4 on
right of the panel). When the proteins were mixed at a molar ratio
of 8:1 (RelJ still at 3.75 mM), two protein-DNA complex bands
were observed (band 1 and 2). As the ratio approached 2:1, the
faster migrating band 1 disappeared while a more slowly migrating
band 4 appeared. At a ratio of 1:1, another band 3 appeared (Lane
7–9). No inhibition was observed with increasing ratios of RelJ/
RelK in the reaction mixtures (Fig. 2D, lane 7–9).
To further test the specificity of the interactions between RelBE-
like pairs and their promoters, we conducted a competitive
experiment. As shown in Fig. 2E, when the labeled DNA
substrates remained constant (5 nM), the amount of complex
formation between RelBE-like proteins and DNA was significantly
decreased and even the bands were disappeared as the
concentration of their respective non-labeled promoter DNA
substrates (from 25 nM to 250 nM) was raised. This indicated that
all three RelBE-like proteins could specifically bind with their
promoters.
Identification of RelBE binding domains within rel
promoters
The binding sites and target sequence recognized by RelBE-like
proteins are unknown in M. tuberculosis. The DNA-binding domain
for M. tuberculosis RelBE proteins was mapped using several short
duplex DNA substrates, designated as p5, p3, and p7. These were
synthesized to cover different regions within the promoter of each
relBE-like operon (Fig. 3, right panels; and Table S1 and Table
S2). Using these specific DNA substrates, we examined the DNA-
binding activities of each RelBE-like pair.
As shown in Fig. 3A, no protein-DNA complex was observed
using 1247p5 as a probe (first column). In contrast, a shifted band
appeared with stepwise increases in the amount of RelE (from 1.8
to 15 mM) when either 1247p3 (second column) or 1247p7 (third
column) were used as DNA substrates. A DNA-binding domain
for RelE/RelB was characterized within the 1247p7 fragment (31-
bp) (Table S1 and Table S2). Similarly, the domain for RelF/RelG
was characterized within the 2865p7 fragment (33-bp) as shown in
Fig. 3B. For RelJ/RelK, the DNA-binding activities were observed
for either RelJ (7.5 mM) alone or RelJ together with RelK (from
1.8 to 15 mM) on both p3 and p7 DNA substrates (Fig. 3C). These
results were consistent with the observations above on the full-
length 3357p substrate (Fig. 2D). In contrast, no protein/DNA
complex was observed on the p5 substrate (Fig. 3C, first column).
Therefore, 3357p7 (50-bp) retained a DNA-binding domain for
RelJ/RelK.
When analyzing the binding sequence, we found that many
direct repeat, inverted repeat, or direct complement sequence
motifs existed within these p7 DNA substrates (Fig. 3D). When
analyzed using LOGO software, the three sequences appeared to
share some conserved residues, and a consensus sequence of ‘‘N(2–
3)C,N,T,N(4)C,N(3) G,N(4–5) C,N(2)A,N(0–1)T,N(8)’’
was also established (Figure S1). If half of the conserved 3357p7
sequence boxes was mutated, as shown in Figure S2, the binding
ability of RelJK with the DNA obviously decreased. This indicated
that the conserved sequence boxes were important for the
interaction between Rel proteins and their operons.
Interactions between three different M. tuberculosis
RelBE-like modules
To investigate potential communications between different pairs
of M. tuberculosis RelBE proteins, we assayed the protein-protein
interactions among these RelBE-like proteins using bacterial two-
hybrid techniques. As shown in Fig. 4A, a group of co-
transformants grown on selective medium was successfully isolated
(also see Figure S3). A local protein-protein interaction network
was constructed based on the screening experiments (Fig. 4A,
lower right). Either RelB or RelF antitoxin was able to interact
with RelE-like toxin proteins, RelE, RelG, and RelK (Fig. 4A,
lower right).
Surface plasmon resonance (SPR) assay confirmed the interac-
tion of RelB with RelG and RelK. As shown in Fig. 4B, his-tagged
RelB protein was immobilized on a nitrilotriacetate (NTA) chip.
When an increasing amount of GST-tagged RelK protein (20 and
60 nM) was passed over the chip, a significant response of about
400 response units (RU) was observed (Fig. 4B, left panel).
Similarly, a response of 140 response units (RU) was observed for
the interaction between RelB and RelG (Fig. 4B, right panel). In
contrast, no response was observed for GST itself.
Both RelB and RelF physically interacted with all three RelE-
like proteins. This suggested that some co-ordinations might exist
between different RelBE-like pairs found in M. tuberculosis. To test
this possibility, we conducted EMSA assays. As shown in Fig. 4C,
RelG was capable of a similar regulation of the DNA-binding
activity of RelB on its operon promoter (Fig. 4C, left panel) as was
seen for RelB with its cognate RelE toxin protein (Fig. 2B). In
contrast, the protein/DNA complex shift was slowed when the
concentration of RelK toxin protein in the reaction mixture was
increased (Fig. 4C, right panel). No binding was observed for RelK
alone, even at a high protein concentration. Using a similar EMSA
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PLoS ONE | www.plosone.org 3 May 2010 | Volume 5 | Issue 5 | e10672Figure 2. Self-interactions of three M. tuberculosis relBE-like modules. Electrophoretic mobility shift assays (EMSA) were used to detect the
binding of RelBE proteins with their operon promoters. A fixed amount of
32P-labeled DNA substrate was incubated with various amounts of proteins
in a total volume of 15 mL of an EMSA buffer. Electrophoresis was performed and gels were exposed to a storage-phosphor screen overnight as
described in the ‘‘Materials and Methods’’. The images were acquired by Typhoon Scanner (GE Healthcare). Both DNA substrate and protein/DNA
complexes are indicated by arrows on the left of the figure. (A) Different amount of each RelB-like protein (3.75 mM, 7.5 mM, and 15 mM ) interacts
with their promoter DNA. (B) The concentration of Rv1247c remains constant at 7.5 mM. The interaction between various ratio of RelE/RelB (8:1, 4:1,
2:1, 1:1, 1:2, 1:4) and a fixed amount of DNA substrate. (C) The concentration of RelF remains constant at 7.5 mM. The interaction between different
ratio of RelF/RelG (8:1, 4:1, 2:1, 1:1, 1:2, 1:4) and a fixed amount of DNA substrate. (D) The concentration of RelJ remains constant at 3.75 mM. The
interaction between different ratio of RelK/RelJ (8:1, 4:1, 2:1, 1:1, 1:2, 1:4) and a fixed amount of DNA substrate. (E) Competitive assays. Three non-
labeled promoter DNA substrates (5-fold, 10-fold or 50-fold) were used to compete with their corresponding labeled DNA substrates. The species of
promoter DNA was indicated on top of each panel in the figure.
doi:10.1371/journal.pone.0010672.g002
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PLoS ONE | www.plosone.org 4 May 2010 | Volume 5 | Issue 5 | e10672Figure 3. Identification of RelBE binding domains within rel promoters. Several short duplex DNA substrates, p5, p3, and p7, were
synthesized, which cover different regions within the upstream sequence of each relBE operon. These are indicated on the right of the figure. EMSA
assays examined the DNA-binding activities of each RelBE pair. The specific DNA substrate was incubated with increasing amounts of RelB-like
protein (1.8 mM, 3.6 mM, 7.5 mM, and 15 mM) in a total volume of 15 mL EMSA buffer. 7.5 mM of each RelB-like or RelE-like protein alone was used a
control for detecting their respective binding with DNA in each EMSA experiment. Electrophoresis was performed and gels were exposed to a
storage-phosphor screen overnight as described in the ‘‘Materials and Methods’’. DNA substrate and protein/DNA complex were indicated by arrows
on the left of the figure. (A) The interaction between RelB/RelE and different regions of its operon promoter. (B) The interaction between different
ratio of RelF/RelG and different regions of its operon promoter. (C) The interaction between different ratio of RelJ/RelK and different regions of its
operon promoter. (D) Structural and sequence characteristics of DNA-binding sites within three relBE operon promoters. IR represents inverted
repeat, DR represents direct repeat, DC represents direct complement, and MR represents migrated repeat. All of these sequence motifs are indicated
by different arrow types above the corresponding sequences.
doi:10.1371/journal.pone.0010672.g003
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PLoS ONE | www.plosone.org 5 May 2010 | Volume 5 | Issue 5 | e10672Figure 4. Cross interactions between three pairs of M. tuberculosis relBE-like proteins. (A) The BacterioMatch II two-hybrid system
(Stratagene) was used to detect protein-protein interactions of different pairs of RelBE proteins, as described in the ‘‘Materials and Methods’’. Upper
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RelF antitoxin protein on its operon promoter (Figure S4A).
However, we did not observe the expected effect of RelK on the
binding activity of RelF (Figure S4B).
Cross-regulation of the different M. tuberculosis RelBE-like
modules
Cross regulation between different RelBE modules was
examined with several mycobacterial growth curves of recombi-
nant M. smegmatis strains, with or without induction by tetracycline
(Fig. 5). Significant growth inhibition was observed for the
recombinant M. smegmatis strain containing relG alone when
induced by tetracycline (Fig. 5C, middle panel). This inhibitory
effect was almost eliminated in the relBG strain, indicating that the
inhibition conferred by relG could be rescued by the antitoxin gene
relB (Fig. 5C, right panel). This effect was consistent with the
physical interaction results (Fig. 4C). No growth inhibition was
observed for the M. smegmatis control strain (Fig. 5C, left panel).
Similarly, as shown in Fig.5D (left and middle panels), an
inhibitory effect by relE and a rescue by relB were observed.
However, relF was unable to rescue the inhibition conferred by
relE, despite the physical interaction indicated earlier between
RelE and RelF (Fig. 4A). Compared to the relE toxin gene alone,
significantly more inhibition was conferred by relEF (Fig. 5D, right
panel). No inhibition was observed with the relF antitoxin gene
expression alone (data not shown). Significant inhibitions were also
conferred by relBK and relFK (Fig. 5E).
To determine if these rel genes were expressed at comparable
levels in the recombinant M. smegmatis strain, specific primers were
synthesized (Table S1) and RT-PCR experiments were conducted.
As shown in Fig. 6, all rel genes or relBE-like gene pairs were
expressed similarly because the predicted sizes of their cDNA
fragments were amplified at similar levels (Fig. 6, right panel).
Therefore, complex cross-regulations were observed between
different M. tuberculosis RelBE-like modules. The relB antitoxin
gene could replace relF to cross-neutralize the relG toxin gene.
Conversely, relF enhanced the toxicity of the relE toxin gene; while
relB could increase the toxicity of the relK toxin gene. relF had no
obvious effect on the toxicity of relK.
Discussion
Bacterial toxin-antitoxin systems may play crucial roles in
controlling dormant infection processes in a number of pathogens
[8]. For M. tuberculosis, its dormancy within a macrophage could
potentially be mediated by three pairs of relBE-like genes that are
expressed during infection [21]. In the present study, the DNA-
binding domain recognized by three RelBE-like pairs and its
structural characteristics were revealed. The cross-regulation of
the rel toxin-antitoxin modules was also confirmed for this unique
pathogen.
The three M. tuberculosis RelE-like toxin proteins physically
interacted with the same RelB-like antitoxin protein. In addition,
all three could conditionally regulate the binding of RelB binding
with promoter DNA. Complex cross regulating effects of these
three RelBE-like modules were also seen on mycobacterial growth
in M. smegmatis. For example, relB could replace relF to cross-
neutralize the toxin protein relG. Conversely, relF increased the
toxicity of toxin protein relE, while relB increased that of relK. This
is the first report of interactions between different pairs of
mycobacterial RelBE modules in M. smegmatis.
We consistently observed that the RelJ was the only antitoxin
that could bind on its own with the promoter region at a relatively
low protein concentration (Fig. 2, 3). No binding activity was
observed for the other two RelB-like antitoxin proteins (RelB and
RelF), even at very high protein concentrations (Fig. 2, 3).
However, using a promoter-lacZ fusion reporter system, Korch et al
recently observed that relB and relF antitoxins on their own could
activate the expression of their operons, even though their TA
complexes inhibited this expression [21]. One likely explanation is
that the binding of RelB or RelF to the promoters might be highly
unstable in the absence of complex formation with their respective
toxin proteins (RelE and RelG). An in vitro assay, such as EMSA,
may not be successfully measure this binding as the protein/DNA
complex would be unstable. On the other hand, some as yet
uncharacterized in vivo interactions may also exist for these
antitoxins, which might control the expression of their operons.
Differential interactions between these toxins and their promoters
are likely to be essential for survival of M. tuberculosis in a dormant
state.
Additional multiple protein/DNA complexes were observed for
the interaction of RelJ/RelK with its promoter DNA (Fig. 2D).
The DNA-binding activity of the RelJK was constant, even in the
presence of increasing amounts of the RelK toxin protein in the
reaction mixture. In contrast, the relatively simple protein-DNA
bands for RelB/RelE and RelF/RelG showed a conditional
cooperativity, as these bands disappeared as the ratio of RelE/
RelB-like proteins was increased (Fig. 2B, C). These in vitro
experiments confirmed the existence of different patterns of
interactions between the M. tuberculosis RelBE proteins and their
operon promoter, which was consistent with the previous in vivo
transcriptional analysis reported by the Clark-Curtiss group [21].
On the other hand, multiple inverted repeat motifs were found
within the characterized binding site for RelJ/RelK, which is
similar to the situation described for E. coli rel operon modules
[19]. However, the sequence motifs within both the RelB/RelE
and the RelF/RelG operon modules appeared to have additional
complexity, including direct repeat (DR), direct complement (DC),
right panel: an outline of the upper left panel plates (CK+: co-transformant containing pBT-LGF2 and pTRG-Gal11P as a positive control. CK-: co-
transformant containing pBT and pTRG as a negative control). Each unit represents the corresponding co-transformant in the plates. Lower left panel:
plate plus 10 mg/mL str and 6 mM 3AT. Lower right panel: a summarized network of protein-protein interactions between these RelBE proteins. The
black circle represents toxin and the white circle represents antitoxin. (B) SPR assays. The interactions of RelB with RelK and RelG were monitored
using surface plasmon resonance on a BIAcore 3000 (GE healthcare). The surface of the chip was activated by saturating the nitrilotriaceticacid sites
with running buffer (100 mM Hepes-NaOH, pH 75, 50 mM EDTA, 0.1 mM dithiothreitol, 50 mM NaCl) containing 0.5 mM NiCl2. In all graphs, time
(seconds) is plotted on the X-axis; response units (RU) are plotted on the y axis. Five nmol of histidine-tagged RelB proteins were immobilized on the
chip surface. Following a period of stabilization, each GST protein was passed over the chip and then allowed to dissociate for 10 min. Overlay plots
depicting the interactions were produced. (C) EMSA was used to detect the cross-regulations on the binding of RelBE with Rv1247c operon promoter.
Electrophoresis was performed and gels were exposed to a storage-phosphor screen overnight as described in the ‘‘Materials and Methods’’. Both
DNA substrate and protein/DNA complex were indicated by arrows on the left of the figure. 7.5 mM of each of RelB-like and RelE-like protein alone
was used a control for detecting their respective binding with DNA. Left panel shows the cross interaction between RelB (7.5 mM) and various
concentrations of RelG (2.5 mM, 5 mM, 6 mM, 7.5 mM, 11.25 mM, and 15 mM); right panel shows the interaction between RelB (7.5 mM) and various
concentrations of RelK(2.5 mM, 5 mM, 6 mM, 7.5 mM, 11.25 mM, and 15 mM).
doi:10.1371/journal.pone.0010672.g004
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PLoS ONE | www.plosone.org 7 May 2010 | Volume 5 | Issue 5 | e10672Figure 5. Cross regulation between different M. tuberculosis relBE-like proteins on the mycobacterial growth. The single rel gene or
relBE, relBG, relBK, and relFE gene pairs were cloned. A TetR-controlled expression system was used to analyze the effects of relBE-like genes on the
growth of M. smegmatis mc
2 155 as described in the ‘‘Materials and Methods’’. The growth of these recombinant mycobacterial strains were
examined in the presence (induction) or absence (no induction) of tetracycline (Tc). Aliquots were taken at the indicated times and the OD600 was
measured. Each analysis was performed in triplicate. The representative growth curves were plotted. (A) Schematic representation of relBE, relBG,
relBK, relFK, and relFE. The GTG start codons are indicated with a line above the codons, and the TGA stop codons are underlined. (B) The locations of
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variations in regulation patterns seen for Rel proteins may have
communication functions, allowing M. tuberculosis to interact with
the unique environment within macrophages.
In the current study, we confirmed that cross interactions occur in
vitro between different M. tuberculosis RelBE pairs and in vivo in M.
smegmatis. Construction of a local protein-protein interaction
network revealed the unexpected result that the RelB and RelF
toxin proteins physically interacted with all three RelE-like toxins.
The RelK toxin protein had a similar effect on the DNA-binding
activity of RelB to its cognate RelE (Fig. 4C). RelG also stimulated
the binding of RelB to the operon promoter. These findings suggest
that cross regulation occurs between the different M. tuberculosis
RelBE-like pairs. The additional finding that the relB antitoxin gene
could interact with the relG toxin gene allows for the possibility that
relB may replace relF to cross-neutralize relG. Our in vivo growth
experiments, which showed that inhibition conferred by relG could
be rescued by relB (Fig. 5C), strongly support this possibility.
Using SCOTS analysis, Korch et al recently observed that two
M. tuberculosis toxins, RelE and RelK, and one antitoxin RelF,
were expressed at the later stages of macrophage infection [21],
but the biological significance of this was unclear. In the current
study, we found that both the RelE and RelK toxins physically
interacted with RelF antitoxin (Fig. 4A). In further experiments,
RelE toxin was observed to stimulate the DNA-binding activity of
RelF antitoxin on its operon promoter (Fig. S4A), while relF
antitoxin expression enhanced the inhibition of mycobacterial
growth by relE toxin expression in M. smegmatis (Fig. 5D).
Interestingly, compared with relE, relK toxin expression alone
strongly inhibited the mycobacterial growth (Fig. 5E, left panel)
and the relF antitoxin expression did not reduce the inhibition
(Fig. 5E, right panel). Our results therefore support a model in
which the expression of relE, relF and relK might promote
persistence of this pathogen by cooperatively arresting bacterial
growth at later stages of macrophage infection [21]. M. tuberculosis
might use some unique rel regulation models to allow it to adapt to
the harsh environmental conditions it encounters as it infects a
macrophage. Although the exact mechanism of the growth arrest
induced by these different RelBE modules remains to be
elucidated, the characterization of auto-regulation and cross-
regulation presented here provides important information for
further research directions.
Materials and Methods
Strains, enzymes, plasmids and reagents
E.coliBL21cellsandpET28awerepurchasedfromNovagen and
used to express M. tuberculosis proteins (Table 1 and 2). pBT, pTRG
vectors and E. coli XR host strains were purchased from Stratagene
(Table 1 and 2). Restriction enzymes, T4 ligase, modification
enzymes, Pyrobest DNA polymerase, dNTPs and all antibiotics
were from TaKaRa Biotech. The reagents for one-hybrid assay and
two-hybrid assay were purchased from Stratagene. PCR primers
were synthesized by Invitrogen (Table S1). Ni-NTA (Ni
2+-
nitrilotriacetate) agarose was obtained from Qiagen.
DNA substrate preparation for DNA-binding activity
assays
DNA substrates used in this study include long promoter DNA
of three relBE modules and their partial fragments. These
promoter DNAs, 1247p, 2865p, and 3357p, were amplified by
PCR from M. tuberculosis H37Rv genomic DNA using their specific
primers (Table S1 and Table S2). Short DNA fragments were
either amplified by PCR or synthesized directly by Invitrogen
(Table S3). The amplified products were purified with the BioFlux
PCR DNA Purification kit (BioFlux) and labeled with T4
polynucleotide kinase (Takara) and [c-
32P] ATP following the
manufacturer’s instructions. The mixture was treated at 65uC for
7 min to inactivate the protein kinase in the reactions. The labeled
DNA substrates were stored at 220uC until use. The synthesized
oligonucleotide was radioactively labeled at its 59-terminus with
T4 polynucleotide kinase (Takara) and [c-
32P] ATP. The labeled
oligonucleotide was purified as described previously [22], then 1.2
fold unlabelled reverse oligonucleotide was added and incubated
at 95uC for 10 min to allow complete annealing. The double DNA
substrates were stored at 220uC for use.
Electrophoretic mobility shift assay (EMSA)
The binding of RelBE proteins to DNA was performed using a
modification of an electrophoretic mobility shift assay (EMSA).
Figure 6. RT-PCR assays for the expressions of M. tuberculosis
relBE-like proteins in M. smegmatis mc
2 155. The experiments and
assays were performed as described in the ‘‘Materials and Methods’’.
Target genes and their host recombinant strains were demonstrated on
the left of panel in the figure. The appropriate sites of each pair of RT-
PCR primers were indicated by arrows. The RT-PCR products were
detected on 1.5% agarose gel as shown on the right of the panel. Lane
1, positive control (the total DNA of each recombinant strain was used a
template for PCR); lane 2, negative control (the cDNA of recombinant
strain YM0 was used a template for PCR); lane 3, RT-PCT products (the
cDNA of each recombinant strain was used a template for PCR).
doi:10.1371/journal.pone.0010672.g006
these genes on the recombinant plasmids. The corresponding strains were demonstrated on the right of the figure panel. (C) The effects of single
relG or relBG pair on the growth of M. smegmatis mc
2 155 in the presence (induction) or absence (no induction) of tetracycline (Tc). (D) The effects of
single relE or relBE and relEF pairs on the growth of M. smegmatis mc
2 155. (E) The effects of single relK or relBK and relFK pair on the growth of M.
smegmatis in the presence (induction) or absence (no induction) of Tc.
doi:10.1371/journal.pone.0010672.g005
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32P-labeled DNA
fragments, and various concentrations (from 0.5 to 30 mM) of
RelB/RelE or their mixed proteins. The reaction mixtures were
incubated at 4uC for 30 min in a total volume of 15 mLo fa n
EMSA buffer consisting of 50 mM Tris-HCl, pH7.5, 10 mM
MgCl2, 1 mM DTT, and 50 mM NaCl. The mixtures were
directly subjected to 5% native PAGE containing 0.56 Tris-
borate-EDTA (TBE) buffer. Electrophoresis was performed at
200 V at 4uC or in an ice-bath until the bromophenol blue
indicator dye reached the bottom of the gel. Gels were exposed
to a storage-phosphor screen overnight at room temperature.
The images were acquired by a Typhoon Scanner (GE
healthcare).
Cloning, expression and purification of recombinant
proteins
Three relB and relE genes were amplified by PCR using their
specific primer pairs (Table S1 and Table S2) from genomic DNA
of M. tuberculosis. These genes were cloned into the modified
pET28a or pGEX-4T-1 expression vectors to produce recombi-
nant plasmids (Table 1). E. coli BL21 cells transformed with the
recombinant plasmid was grown in 200 mL of LB medium up to
an OD600 of 0.6. Protein expression was induced by the addition
of 0.3 mM Isopropyl b-D-1-thiogalactopyranoside (IPTG). Har-
vested cells were resuspended and sonicated in binding buffer
(100 mM Tris-HCl, pH 8.0, 500 mM NaCl, and 10 mM
imidazole for his-tagged proteins or 1x PBS buffer for GST-
tagged proteins) and lysate was centrifuged at 100006g for
30 min. The cleared supernatant was loaded onto an affinity
column and washed with wash buffer (100 mM Tris-HCl, pH 8.0,
500 mM NaCl, and 40 mM imidazole for his-tagged proteins, or
PBS buffer for GST-tagged proteins). The protein was then eluted
using elution buffer (100 mM Tris-HCl, pH 8.0, 500 mM NaCl,
and 250 mM imidazole for his-tagged proteins or PBS buffer
containing 10 mM reduced glutathione (GSH) for GST-tagged
proteins). The eluate was then dialyzed against the buffer (10mM
Tris-HCl 100 mM NaCl 1 mM DTT 10% glycerol) overnight and
stored at –80uC. Purity of the proteins was greater than 98% as
determined by SDS–PAGE and subsequent staining with
Coomassie Blue.
Bacterial two-hybrid assay
The BacterioMatch II Two-Hybrid System (Stratagene) was
used to establish protein–protein interactions between M.
tuberculosis RelB and RelE proteins as described previously
[23,24]. Three relB and relE genes were amplified by PCR using
their specific primer pairs (Table S1 and Table S2) from genomic
DNA of M. tuberculosis. After digestion with a pair of restriction
enzymes (indicated in Table S1), these gene fragments were cloned
into the modified pBT or pTRG to produce recombinant vectors
(Table 1). A pair of pBT/pTRG plasmids was co-transformed into
the reporter strain and spotted onto screening medium containing
6,8 mM 3-AT, 10,12 mg/mL streptomycin, 15 mg/mL tetracy-
Table 1. Plasmids used in this study.
Plasmid genotype or features
Source or
reference
pMind Kan
r, pAL5000 replicon 5
pMind::relE relE in BamHI-PacI site of pMind This study
pMind::relBE relBE in BamHI-PacI site of pMind This study
pMind::relBG relBG in BamHI-PacI site of pMind This study
pMind::relBK relBK in BamHI-PacI site of pMind This study
pMind::relG relG in BamHI-PacI site of pMind This study
pMind::relFE relFE in BamHI-PacI site of pMind This study
pMind::relK relK in BamHI-PacI site of pMind This study
pBT chlo
r, p15A replicon, lac-UV5 promoter Stratagene
pBT-1246c relE in EcoRI-XbaI sites of pBT This study
pBT-1247c relB in EcoRI-XbaI sites of pBT This study
pBT-2865 relF in EcoRI-NotI sites of pBT This study
pBT-2866 relG in EcoRI-NotI sites of pBT This study
pBT-3357 relJ in EcoRI-XbaI sites of pBT This study
pBT-3358 relK in EcoRI-XbaI sites of pBT This study
pTRG tet
r, ColE1 replicon, lpp/lac-UV5 promoter Stratagene
pTRG-1246c relE in EcoRI-XbaI sites of pTRG This study
pTRG-1247c relB in EcoRI-XbaI sites of pTRG This study
pTRG-2865 relF in EcoRI-NotI sites of pTRG This study
pTRG-2866 relG in EcoRI-NotI sites of pTRG This study
pTRG-3357 relJ in EcoRI-XbaI sites of pTRG This study
pTRG-3358 relK in EcoRI-XbaI sites of pTRG This study
pET28a(+)K a n
r, T7 lac promoter, N-terminal His6 Novagen
pET-1246c relE in EcoRI-XbaI sites of pET28a This study
pET-1247c relB in EcoRI-XbaI sites of pET28a This study
pET-2865 relF in EcoRI-NotI sites of pET28a This study
pET-2866 relG in EcoRI-NotI sites of pET28a This study
pET-3357 relJ in EcoRI-XbaI sites of pET28a This study
pET-3358 relK in EcoRI-XbaI sites of pET28a This study
pGEX Amp
r, pBR322 replicon, tac promoter GE Healthcare
pGEX-1246c relE in EcoRI-XbaI sites of pGEX This study
pGEX-1247c relB in EcoRI-XbaI sites of pGEX This study
pGEX-2865 relF in EcoRI-NotI sites of pGEX This study
pGEX-2866 relG in EcoRI-NotI sites of pGEX This study
pGEX-3357 relJ in EcoRI-XbaI sites of pGEX This study
pGEX-3358 relK in EcoRI-XbaI sites of pGEX This study
doi:10.1371/journal.pone.0010672.t001
Table 2. Strains used in this study.
Strain or plasmid Relevant genotype or features
Source or
reference
E.coli
DH5a Host for plasmid construction TaKaRa
BL21 Host for overexpression TaKaRa
XR Host for bacteria two-hybrid() Stratagene
M. smegmatis mc
2155 30
YM0 mc
2155with pMind This study
YM1 mc
2155with pMind::relE This study
YM11 mc
2155with pMind::relBE This study
YM12 mc
2155with pMind::relBG This study
YM13 mc
2155with pMind::relBK This study
YM2 mc
2155with pMind::relG This study
YM21 mc
2155with pMind::relFE This study
YM3 mc
2155with pMind::relK This study
YM23 mc
2155with pMind::relFK This study
doi:10.1371/journal.pone.0010672.t002
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The plates were incubated at 30uC for 3–4 days. A co-
transformant containing pBT-LGF2 and pTRG-Gal11P (Strata-
gene) was used as a positive control for expected growth on the
Selective Screening Medium. A co-transformant containing empty
vector pBT and pTRG was used as a negative control.
SPR analysis
Surface Plasmon Resonance (SPR) analysis on a Biacore 3000
instrument (GE healthcare) with NTA sensor chips was performed
according to our previous published procedures [22,24,25].
Briefly, His-tagged RelB-like or RelE-like protein was immobilized
onto the NTA chips (Nitrilotriacetic acid chip). The purified GST
RelB-like or RelE-like protein, to be used as the ligand, was diluted
in the HBS buffer (10 mM Hepes (pH 7.4), 150 mM NaCl,
50 mM EDTA, 5 mM ATP, 0.005% BIAcore surfactant P20) at a
concentration of ,200 nM and injected at 10 ml/min for 5 min at
25uC. For a negative control, GST protein was substituted for the
GST-RelBE protein. Each analysis was performed in triplicate. An
overlay plot was produced using BIAevaluation 3.1 software to
depict the interaction between RelBE proteins.
GST pull-down assay
Equimolar amounts of normalized GST or GST-RelB-like
proteins were combined with equimolar amounts of normalized
his-tagged-RelE-like proteins in 1.5 mL tubes containing 500 mLo f
PBS. The protein mixture was gently rocked at 4uC for 4–15 hour.
Before further purification, 60 mL of mixture was removed and
saved as a loading control. The remaining mixtures were then
purified using the GST-affinity assay as described above. All
samples were subjected to SDS-PAGE and detected by Coomassie
bluestaining.ImageswerethenacquiredbyGel DocXR(Bio-Rad).
Assay for toxin growth inhibition
A TetR-controlled expression system was used to analyze the
effects of relBE-like genes on the growth of M. smegmatis mc
2 155
[26]. Three toxin genes-relE, relG, and relK-were cloned separately
into pMind [27] and the plasmids pMind:relE, pMind:relG and
pMind:relK were produced (Table 1). These recombinant plasmids
were then transformed into M. smegmatis to generate recombinant
strains YM1, YM2, and YM3, respectively (Table 2). The relBE,
relBG, relBK, and relFE gene pairs were also cloned and
transformed into M. smegmatis to generate corresponding recom-
binant strainsYM11, YM12, YM13, YM21 and YM23 respec-
tively (Table 2). The strain YM0, containing the empty pMind
plasmid (Table 2), was used as negative control. In all assays,
tetracycline was used to induce gene expression [28]. The growth
of these recombinant mycobacterial strains were examined in the
presence (induction) or absence (no induction) of tetracycline (Tc).
Cells were grown at 37uC with aeration in 7H9-Kan-Tw (7H9
medium supplemented with 0.5% Tween 80, 30 mg/mL kanamy-
cin, and 0.2% glycerol). When cells entered into a stationary
growth phase with an OD600 of 1.5 to 2.0, the cultures were
diluted in 7H9-Kan-Tw medium to an OD600 of 0.2, with an
additional growth at 37uC at 200 rpm for 2 hours, and were split
for induction with 20 mg/mL Tc vs no induction. Aliquots were
taken at the indicated times, and the OD600 was measured. Each
analysis was performed in triplicate. The representative growth
curves are plotted in the figures.
RT-PCR assays
RNA was isolated from M. smegmatis mc
2 155 recombinant
strains YM1, YM2, YM11,YM12, YM21, YM23, and YM0
(Table 2), respectively. For Reverse-transcription PCR, RNA of
recombinant strains was used as a template for synthesis of cDNA
using a ReverTra Ace first-strand cDNA synthesis kit(TOYOBO,
JAPAN) and reverse primers (Invitrogen) according to the
manufacturer’s instructions. The cDNA was used to amplify a
product encompassing the some parts of relE, relG, relBE, relBG,
relFK, relFE genes using their specific primers (Table S1). For a
positive control, the total DNA of each recombinant strain was
used as a template to amplify a product. The cDNA of
recombinant strain (YM0) was used as a template for a negative
control. The PCR products were detected on 1.5% agarose gel.
Supporting Information
Table S1 Primers used in the construction of recombinant
vectors.
Found at: doi:10.1371/journal.pone.0010672.s001 (0.07 MB
DOC)
Table S2 S2 Primers used for amplifying promoter DNA
fragments.
Found at: doi:10.1371/journal.pone.0010672.s002 (0.05 MB
DOC)
Table S3 DNA substrate fragment synthesized for EMSA
assays.
Found at: doi:10.1371/journal.pone.0010672.s003 (0.03 MB
DOC)
Figure S1 LOGO assays for the consensus sequence of three
RelBE-binding sites of M. tuberculosis. Sequence alignment was
carried by ClustalW toolkit and visualized by BioEdit software
locally. Sequence logo were generated by WebLogo tool version
2.8.2 with some parameter optimized according its manual book.
Found at: doi:10.1371/journal.pone.0010672.s004 (0.20 MB
DOC)
Figure S2 EMSA assay for comparing the binding of RelK/RelJ
with wild-type and mutant substrates. EMSA and electrophoresis
assays were performed as described in the ‘‘Materials and
Methods’’. Wild-type and mutant 3357p7 were used to compare
the binding of RelK/RelJ with two substrates. 3357p7 mutant
substrates contain mutations within the half of the conserved
3357p7 sequence boxes (DR and MR). The reaction mixtures
contain a constant concentration of RelJ (5 mM) and various
concentrations of RelK (2.5 mM, 5 mM, and 7.5 mM).
Found at: doi:10.1371/journal.pone.0010672.s005 (0.13 MB
DOC)
Figure S3 Cross interactions between three pairs of relBE-like
genes of M. tuberculosis. The BacterioMatch II two-hybrid system
(Stratagene) was used to detect protein-protein interactions of
these RelBE protein pairs, as described in the ‘‘Materials and
Methods’’. Up left panel: plate minus streptomycin (str) and 6 mM
3-amino-1, 2, 4-triazole (3-AT). Up right panel: plate plus 10 mg/
mL str and 6 mM 3AT. Down panel: an outline of the plates in A,
CK+: co-transformant containing pBT-LGF2 and pTRG-Gal11P
as a positive control. CK-: co-transformant containing pBT and
pTRG as a negative control. Each unit represents the correspond-
ing co-transformant in the plates. All recombinant plasmids and
their containing genes were indicated.
Found at: doi:10.1371/journal.pone.0010672.s006 (0.33 MB
DOC)
Figure S4 EMSA was used to detect the cross-regulations on the
bindings of RelFE (A) and RelFK (B) with Rv2865 operon
promoter. Electrophoresis was performed and gels were exposed
to a storage-phosphor screen overnight as described in the
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complex were indicated by arrows on the left of the figure.
Found at: doi:10.1371/journal.pone.0010672.s007 (0.23 MB
DOC)
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